Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial (LIBERTY AD ADOL)

Main Article Content

Lawrence Sher
Weily Soong
Randy Prescilla
Zhen Chen
Ashish Bansal


Atopic Dermatitis, Biologics, Dupilumab, Atopy, Allergic Rhinitis


Abstract not available.


1. Shrestha S, et al. Adv Ther. 2017;34:1989-2006.

2. Silverberg JI, Simpson EL. Pediatr Allergy Immunol. 2013;24:476-86.

3. Gandhi NA, et al. Nat Rev Drug Discov. 2016;15:35-50.

4. Thaçi et al. J Allergy Clin Immunol. 2018;141 Suppl:AB136. Data presented at 2018 American Academy of Allergy, Asthma & Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress; Orlando, FL, USA; March 2–5, 2018; poster P430.

5. Simpson EL, et al. JAMA Dermatol. 2019 Nov 6 [Epub ahead of print]. doi: https://doi.org/10.1001/jamadermatol.2019.3336

6. Prens E, et al. Allergy. 2018;73(S105):3-115 AB0140. Data presented at 2018 European Academy of Allergy and Clinical Immunology (EAACI); Munich, Germany; May 26–30, 2018; oral presentation and poster.

Most read articles by the same author(s)

1 2 > >>